(Q36797701)

16 August 2017

title

Autologous platelet concentrate as an adjunct in macular hole healing: a pilot study (English)

1 reference

16 August 2017

1 reference

J F Korobelnik

1

1 reference

16 August 2017

D Hannouche

2

1 reference

16 August 2017

N Belayachi

3

1 reference

16 August 2017

M Branger

4

1 reference

16 August 2017

J E Guez

5

1 reference

16 August 2017

T Hoang-Xuan

6

1 reference

16 August 2017

publication date

1 April 1996

1 reference

16 August 2017

1 reference

16 August 2017

volume

103

1 reference

16 August 2017

issue

4

1 reference

16 August 2017

page(s)

590-594

1 reference

Idiopathic senile macular hole. Its early stages and pathogenesis

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930648-9

7 January 2021

Idiopathic macular holes. Observations, stages of formation, and implications for surgical intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930648-9

7 January 2021

Vitreous surgery for idiopathic macular holes. Results of a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930648-9

7 January 2021

Vitreous surgery for macular holes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930648-9

7 January 2021

Transforming growth factor-beta 2 for the treatment of full-thickness macular holes. A prospective randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930648-9

7 January 2021

The effect of pars plana vitrectomy and transforming growth factor-beta 2 without epiretinal membrane peeling on full-thickness macular holes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930648-9

7 January 2021

Effects of intraocular bubble duration in the treatment of macular holes by vitrectomy and transforming growth factor-beta 2

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930648-9

7 January 2021

Transforming growth factor beta. A biologic chorioretinal glue

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930648-9

7 January 2021

Retreatment of full-thickness macular holes persisting after prior vitrectomy. A pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930648-9

7 January 2021

Laser photocoagulation and fluid-gas exchange for recurrent macular hole

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930648-9

7 January 2021

Human autologous serum for the treatment of full-thickness macular holes. A preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930648-9

7 January 2021

Autologous platelet concentrate for the treatment of full-thickness macular holes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930648-9

7 January 2021

Classification and treatment of chronic nonhealing wounds. Successful treatment with autologous platelet-derived wound healing factors (PDWHF).

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930648-9

7 January 2021

Posterior segment complications after vitrectomy for macular hole

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930648-9

7 January 2021

10.1016/S0161-6420(96)30648-9

Identifiers

DOI

1 reference

16 August 2017

1 reference